Management of Decompensated Cirrhosis in the Surgical ICU: an American Association for the Surgery of Trauma Critical Care Committee Clinical Consensus Document
暂无分享,去创建一个
Lisa M. Kodadek | J. Cuschieri | C. Michetti | Anupamaa J. Seshadri | K. Kaups | A. Pathak | S. Rudnick | M. Kutcher | J. Hoth | J. Rappold | S. Carmichael | R. Appelbaum | Anupamaa Seshadri
[1] M. Shoreibah,et al. Perioperative Transjugular Intrahepatic Portosystemic Shunt Is Associated With Decreased Postoperative Complications in Decompensated Cirrhotics Undergoing Abdominal Surgery , 2022, The American surgeon.
[2] S. Chandna,et al. Management of Decompensated Cirrhosis and Associated Syndromes. , 2022, The Surgical clinics of North America.
[3] P. Kamath,et al. Acute-on-Chronic Liver Failure Clinical Guidelines , 2022, The American journal of gastroenterology.
[4] C. Thongprayoon,et al. In-hospital mortality of hepatorenal syndrome in the United States: Nationwide inpatient sample , 2021, World journal of gastroenterology.
[5] Y. Arabi,et al. Outcomes of septic cirrhosis patients admitted to the intensive care unit , 2021, Medicine.
[6] A. Davis,et al. Managing Adult Acute and Acute-on-Chronic Liver Failure in the ICU. , 2021, JAMA.
[7] B. Crichi,et al. Hemostasis testing in patients with liver dysfunction: Advantages and caveats , 2021, World Journal of Gastroenterology.
[8] Y. Takei,et al. Update on blood‐based biomarkers for chronic liver diseases prognosis: Literature review and institutional experience , 2021, JGH open : an open access journal of gastroenterology and hepatology.
[9] Yuan Xu,et al. Hepatorenal syndrome in acute-on-chronic liver failure with acute kidney injury: more questions requiring discussion , 2021, Gastroenterology report.
[10] Pere Ginès,et al. Liver cirrhosis , 2021, The Lancet.
[11] Chih-Wei Tseng,et al. Prognosis of hypoglycemia episode in cirrhotic patients during hospitalization , 2021, BMC Gastroenterology.
[12] W. Kim,et al. Diagnosis, Evaluation, and Management of Ascites, Spontaneous Bacterial Peritonitis and Hepatorenal Syndrome: 2021 Practice Guidance by the American Association for the Study of Liver Diseases , 2021 .
[13] J. Lai,et al. Malnutrition, Frailty, and Sarcopenia in Patients With Cirrhosis: 2021 Practice Guidance by the American Association for the Study of Liver Diseases , 2021, Hepatology.
[14] V. Sundaram,et al. Treatment of Severe Acute on Chronic Liver Failure: Management of Organ Failures, Investigational Therapeutics, and the Role of Liver Transplantation. , 2021, Journal of clinical gastroenterology.
[15] W. Kim,et al. Diagnosis, Evaluation, and Management of Ascites, Spontaneous Bacterial Peritonitis and Hepatorenal Syndrome: 2021 Practice Guidance by the American Association for the Study of Liver Diseases , 2021, Hepatology.
[16] A. Barkun,et al. ACG Clinical Guideline: Upper Gastrointestinal and Ulcer Bleeding , 2021, The American journal of gastroenterology.
[17] M. Rudler,et al. Diagnosis and Management of Hepatic Encephalopathy , 2021, Springer International Publishing.
[18] Douglas A. Simonetto,et al. Terlipressin plus Albumin for the Treatment of Type 1 Hepatorenal Syndrome. , 2021, The New England journal of medicine.
[19] Kamal Kajal,et al. Point-of-Care Echocardiography and Hemodynamic Monitoring in Cirrhosis and Acute-on-Chronic Liver Failure in the COVID-19 Era , 2021, Journal of intensive care medicine.
[20] D. Valla,et al. Vascular Liver Disorders, Portal Vein Thrombosis, and Procedural Bleeding in Patients With Liver Disease: 2020 Practice Guidance by the American Association for the Study of Liver Diseases , 2020, Hepatology.
[21] M. Plauth,et al. ESPEN practical guideline: Clinical nutrition in liver disease. , 2020, Clinical nutrition.
[22] Douglas A. Simonetto,et al. Hepatorenal syndrome: pathophysiology, diagnosis, and management , 2020, BMJ.
[23] N. Terrault,et al. Thrombopoietin Receptor Agonists in Patients with Chronic Liver Disease , 2020, Seminars in Thrombosis and Hemostasis.
[24] D. Rockey,et al. Ammonia Levels Do Not Guide Clinical Management of Patients With Hepatic Encephalopathy Caused by Cirrhosis. , 2020, The American journal of gastroenterology.
[25] R. Talukdar,et al. Pathophysiology and Prevention of Paracentesis-induced Circulatory Dysfunction: A Concise Review , 2020, Journal of clinical and translational hepatology.
[26] C. Michetti,et al. Contemporary hemodynamic monitoring, fluid responsiveness, volume optimization, and endpoints of resuscitation: an AAST critical care committee clinical consensus , 2020, Trauma Surgery & Acute Care Open.
[27] T. Lisman. Interpreting Hemostatic Profiles Assessed With Viscoelastic Tests in Patients With Cirrhosis. , 2020, Journal of clinical gastroenterology.
[28] T. H. Nguyen,et al. The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 , 2020, The lancet. Gastroenterology & hepatology.
[29] R. Bellomo,et al. Effect of Stress Ulcer Prophylaxis With Proton Pump Inhibitors vs Histamine-2 Receptor Blockers on In-Hospital Mortality Among ICU Patients Receiving Invasive Mechanical Ventilation: The PEPTIC Randomized Clinical Trial. , 2020, JAMA.
[30] P. Angeli,et al. News in Pathophysiology, Definition and Classification of Hepatorenal Syndrome: a step beyond the International Club of Ascites (ICA) Consensus document. , 2019, Journal of hepatology.
[31] Kira L. Newman,et al. Perioperative Evaluation and Management of Patients with Cirrhosis: Risk Assessment, Surgical Outcomes, and Future Directions. , 2019, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[32] D. Valla,et al. Anticoagulation in the cirrhotic patient , 2019, JHEP reports.
[33] S. Caldwell,et al. AGA Clinical Practice Update: Coagulation in Cirrhosis. , 2019, Gastroenterology.
[34] R. Vora,et al. Hypotension in Cirrhosis , 2019, Clinical liver disease.
[35] M. Plauth,et al. ESPEN guideline on clinical nutrition in liver disease. , 2019, Clinical nutrition.
[36] Kamal Kajal,et al. Noninvasive estimation of intravascular volume status in cirrhosis by dynamic size and collapsibility indices of the inferior vena cava using bedside echocardiography , 2019, JGH open : an open access journal of gastroenterology and hepatology.
[37] P. Kamath,et al. AGA Clinical Practice Update on Surgical Risk Assessment and Perioperative Management in Cirrhosis: Expert Review , 2019, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[38] M. Mcphail,et al. l-Ornithine l-Aspartate (LOLA) for Hepatic Encephalopathy in Cirrhosis: Results of Randomized Controlled Trials and Meta-Analyses , 2019, Drugs.
[39] F. Nevens,et al. Recommendations on the Diagnosis and Initial Management of Acute Variceal Bleeding and Hepatorenal Syndrome in Patients with Cirrhosis , 2019, Digestive Diseases and Sciences.
[40] P. Kamphuisen,et al. Haemostatic Profiles are Similar across All Aetiologies of Cirrhosis , 2019, Thrombosis and Haemostasis.
[41] M. Abecassis,et al. Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases , 2019, Clinical Liver Disease.
[42] N. Weiss,et al. Why and when to measure ammonemia in cirrhosis? , 2018, Clinics and research in hepatology and gastroenterology.
[43] P. Suñé,et al. Midodrine and albumin for prevention of complications in patients with cirrhosis awaiting liver transplantation. A randomized placebo-controlled trial. , 2018, Journal of hepatology.
[44] Robert S. Brown,et al. Critical Care Management of Gastrointestinal Bleeding and Ascites in Liver Failure , 2018, Seminars in Respiratory and Critical Care Medicine.
[45] S. Jaber,et al. Shock Etiologies and Fluid Management in Liver Failure , 2018, Seminars in Respiratory and Critical Care Medicine.
[46] B. Thornburg,et al. Preoperative Transjugular Intrahepatic Portosystemic Shunt Placement for Extrahepatic Abdominal Surgery , 2018, Seminars in Interventional Radiology.
[47] J. Trebicka,et al. EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis. , 2018, Journal of hepatology.
[48] J. Abdo-Francis,et al. Primary Prophylaxis to Prevent the Development of Hepatic Encephalopathy in Cirrhotic Patients with Acute Variceal Bleeding , 2018, Canadian journal of gastroenterology & hepatology.
[49] A. Gasbarrini,et al. Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial , 2018, The Lancet.
[50] N. Weiss,et al. Treating hepatic encephalopathy in cirrhotic patients admitted to ICU with sodium phenylbutyrate: a preliminary study , 2018, Fundamental & clinical pharmacology.
[51] M. Rössle,et al. Transjugular intrahepatic portosystemic shunt for hepatorenal syndrome: A systematic review and meta-analysis. , 2018, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.
[52] Deepanshu Jain,et al. Preoperative elective transjugular intrahepatic portosystemic shunt for cirrhotic patients undergoing abdominal surgery , 2018, Annals of gastroenterology.
[53] H. Verspaget,et al. Copeptin in acute decompensation of liver cirrhosis: relationship with acute-on-chronic liver failure and short-term survival , 2017, Critical Care.
[54] E. Maynard. Decompensated Cirrhosis and Fluid Resuscitation. , 2017, The Surgical clinics of North America.
[55] C. Karvellas,et al. Critical care management of the patient with cirrhosis awaiting liver transplant in the intensive care unit , 2017, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[56] M. Morgan,et al. Flumazenil versus placebo or no intervention for people with cirrhosis and hepatic encephalopathy. , 2017, The Cochrane database of systematic reviews.
[57] F. Nevens,et al. Plasma cystatin C is a predictor of renal dysfunction, acute‐on‐chronic liver failure, and mortality in patients with acutely decompensated liver cirrhosis , 2017, Hepatology.
[58] M. Merli,et al. A practical approach to nutritional screening and assessment in cirrhosis , 2017, Hepatology.
[59] A. Webster,et al. Probiotics for people with hepatic encephalopathy. , 2017, The Cochrane database of systematic reviews.
[60] R. Bruno,et al. Consensus conference on TIPS management: Techniques, indications, contraindications. , 2017, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.
[61] S. Basili,et al. Low‐grade endotoxemia and platelet activation in cirrhosis , 2017, Hepatology.
[62] J. Bosch,et al. Portal hypertensive bleeding in cirrhosis: Risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the study of liver diseases , 2017, Hepatology.
[63] P. Ambrosino,et al. The risk of venous thromboembolism in patients with cirrhosis , 2016, Thrombosis and Haemostasis.
[64] P. Marik. Fluid Responsiveness and the Six Guiding Principles of Fluid Resuscitation , 2016, Critical care medicine.
[65] M. Morgan,et al. Nonabsorbable disaccharides for hepatic encephalopathy: A systematic review and meta‐analysis , 2016, Hepatology.
[66] B. Runyon,et al. Treatment of Patients with Cirrhosis. , 2016, The New England journal of medicine.
[67] J. Jeong,et al. CLIF–SOFA score and SIRS are independent prognostic factors in patients with hepatic encephalopathy due to alcoholic liver cirrhosis , 2016, Medicine.
[68] R. Regal,et al. Anticoagulation in Patients With Cirrhosis , 2016, The Annals of pharmacotherapy.
[69] M. Ronsoni,et al. Single‐centre validation of the EASL‐CLIF Consortium definition of acute‐on‐chronic liver failure and CLIF‐SOFA for prediction of mortality in cirrhosis , 2015, Liver international : official journal of the International Association for the Study of the Liver.
[70] David B Hoyt,et al. Transfusion of plasma, platelets, and red blood cells in a 1:1:1 vs a 1:1:2 ratio and mortality in patients with severe trauma: the PROPPR randomized clinical trial. , 2015, JAMA.
[71] A. Fuentes,et al. Comparison of Anti-Xa and Activated Partial Thromboplastin Time Monitoring for Heparin Dosing in Patients With Cirrhosis , 2015, Therapeutic drug monitoring.
[72] D. Rockey,et al. Lactulose vs polyethylene glycol 3350--electrolyte solution for treatment of overt hepatic encephalopathy: the HELP randomized clinical trial. , 2014, JAMA internal medicine.
[73] V. Novack,et al. Emergency hernia repair in cirrhotic patients with ascites , 2013, The journal of trauma and acute care surgery.
[74] B. Sharma,et al. A Randomized, Double-Blind, Controlled Trial Comparing Rifaximin Plus Lactulose With Lactulose Alone in Treatment of Overt Hepatic Encephalopathy , 2013, The American Journal of Gastroenterology.
[75] A. Davenport,et al. Can non-invasive measurements aid clinical assessment of volume in patients with cirrhosis? , 2013, World journal of hepatology.
[76] P. Mannucci,et al. Evidence that low protein C contributes to the procoagulant imbalance in cirrhosis. , 2013, Journal of hepatology.
[77] R. Porte,et al. An unbalance between von Willebrand factor and ADAMTS13 in acute liver failure: Implications for hemostasis and clinical outcome , 2013, Hepatology.
[78] P. Kamath,et al. Acute-on chronic liver failure. , 2012, Journal of hepatology.
[79] D. Valla,et al. Enoxaparin prevents portal vein thrombosis and liver decompensation in patients with advanced cirrhosis. , 2012, Gastroenterology.
[80] C. Divino,et al. Complicated hernia presentation in patients with advanced cirrhosis and refractory ascites: management and outcome. , 2010, Surgery.
[81] O. Dabbagh,et al. Coagulopathy does not protect against venous thromboembolism in hospitalized patients with chronic liver disease. , 2008, Chest.
[82] Samuel Z Goldhaber,et al. Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study , 2008, The Lancet.
[83] B. Schneeweiss,et al. Acid–base disturbances in critically ill patients with cirrhosis , 2007, Liver international : official journal of the International Association for the Study of the Liver.
[84] R. Ruiz. Hepatic Failure , 2007, Clinical pediatrics.
[85] É. Vinet,et al. Transjugular intrahepatic portosystemic shunt before abdominal surgery in cirrhotic patients: a retrospective, comparative study. , 2006, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.
[86] E. Cholongitas,et al. Systematic review: the model for end‐stage liver disease – should it replace Child‐Pugh's classification for assessing prognosis in cirrhosis? , 2005, Alimentary pharmacology & therapeutics.
[87] Evangelos Cholongitas,et al. MELD is not enough--enough of MELD? , 2005, Journal of hepatology.
[88] R. Esteban,et al. Normal protein diet for episodic hepatic encephalopathy: results of a randomized study. , 2004, Journal of hepatology.
[89] S. Fagan,et al. Management of complicated umbilical hernias in patients with end-stage liver disease and refractory ascites. , 2004, Surgery.
[90] J. Bruix,et al. Abdominal drainage after liver resection for hepatocellular carcinoma in cirrhotic patients: a randomized controlled study. , 2004, Hepato-gastroenterology.
[91] S. Fan,et al. Abdominal Drainage After Hepatic Resection Is Contraindicated in Patients With Chronic Liver Diseases , 2004, Annals of surgery.
[92] M. Merli,et al. Role of determination of partial pressure of ammonia in cirrhotic patients with and without hepatic encephalopathy. , 2003, Journal of hepatology.
[93] N. Tygstrup,et al. Glucoregulation in acute liver failure , 1986, European journal of clinical investigation.
[94] G. Práctica,et al. European Association for the Study of the Liver , 1971 .
[95] W. Wyman,et al. Department of Surgery , 1898, The Journal of Comparative Medicine and Veterinary Archives.
[96] Jesse M. Ehrenfeld,et al. Balanced Crystalloids versus Saline in Noncritically Ill Adults , 2018, The New England journal of medicine.
[97] A. Davenport,et al. Medical management of hepatorenal syndrome. , 2012, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[98] A. Lee,et al. Evaluation of an uncalibrated arterial pulse contour cardiac output monitoring system in cirrhotic patients undergoing liver surgery. , 2009, British journal of anaesthesia.
[99] A. B. Sukhomlinov,et al. [Liver cirrhosis]. , 1989, Fel'dsher i akusherka.